Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis

Exclusion Criteria

• •Is in hospice, is receiving end-of-life palliative care, or is bedridden
• •Has psychotic symptoms that are primarily attributable to delirium, substance abuse, or a medical or psychiatric condition (e.g. schizophrenia, bipolar disorder, delusional disorder) other than dementia
• •Is actively suicidal at Visit 1 (Screening) or Visit 2 (Baseline)
• •Has a history or current evidence of a serious and/or significant unstable cardiovascular, respiratory, endocrine, gastrointestinal, renal, hepatic, hematologic, immunologic, genitourinary, psychiatric or neurologic (including stroke, chronic seizures, or clinically significant head injury) abnormality or disease or other medical disorder, including cancer or malignancies that could interfere with subject's ability to complete the study or comply with study procedures
• •Has other clinically significant CNS abnormalities that are most likely contributing to the dementia or findings on MRI or CT